ACQUIRED HAEMOGLOBINOPATHY

This adverse event was reported 5 times

ACQUIRED HAEMOGLOBINOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRASTUZUMAB AND HYALURONIDASE-OYSK 1 0.0093
1 AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE 1 0.0008
2 CEFADROXIL 1 0.0005
3 LITHIUM 1 0.0000
4 PERTUZUMAB 1 0.0000
5 PROCHLORPERAZINE 1 0.0000
6 ERGOCALCIFEROL 1 0.0000
7 OSIMERTINIB 1 0.0000
8 IRON 1 0.0000
9 DOCETAXEL ANHYDROUS 1 0.0000
See all drugs enriched for association with ACQUIRED HAEMOGLOBINOPATHY

ACQUIRED HAEMOGLOBINOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Provitamin D2 Compound [EPC] 1 0.0000
2 Phenothiazine [EPC] 1 0.0000
3 Thiazide-like Diuretic [EPC] 1 0.0000
4 HER2/neu Receptor Antagonist [EPC] 1 0.0000
5 Microtubule Inhibitor [EPC] 1 0.0000
6 Atypical Antipsychotic [EPC] 2 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
8 Osmotic Laxative [EPC] 1 0.0000
9 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
See all drug classes enriched for association with ACQUIRED HAEMOGLOBINOPATHY